Ambu's Q3 ended better than expected

After a downgrade earlier in the year, pessimism had grown regarding Ambu's third quarter, though it turned out to go slightly above expectations. The launch of one of the firm's new products is postponed, however.
Photo: PR / Ambu
Photo: PR / Ambu
by ELIZABETH MØNSTED JOHANSEN, translated by jonas sahl jørgensen

The third-quarter financials of Danish medical technology firm Ambu ended up slightly better than expected earlier this year after the company presented preliminary figures in connection with a downgrade.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading